Medication Reconciliation and Pharmacovigilance with Dr. Clement Goehrs

Long time readers may remember that we covered the announcement of a French company, Synapse Medicine, launching their Medication Reconciliation and Pharmacovigilance solutions in the US.  I always find it exciting when the US can benefit from technology and solutions that are already having an impact internationally.  At the HIMSS 2022 conference, I was able to sit down with Dr. Clement Goehrs, MD-PhD, CEO & Co-Founder Synapse Medicine, to learn more about their solutions and their expansion into the US.

Talking with Dr. Goehrs, I learned that while there are fundamental differences between healthcare in France and the US, the need and process for medication reconciliation was very similar.  This reality was a big reason why Synapse Medicine wanted to bring their solution to the US.  They’d benefited many of the best healthcare organizations in France and they wanted to provide those same benefits to US health systems.

Plus, Dr. Goehrs shares why medication reconciliation is such a hard problem to solve.  It’s full of challenges and requires a lot of time for the pharmacist to do it right.  However, when you apply the right technology, Synapse Medicine has proven that they can go from 1 hour to do medication reconciliation to under 15 minutes.  Plus, Dr. Goehrs found that many pharmacists were having to use multiple tools to do the reconciliation.  Synapse Medicine brings all of the information together from across multiple systems in one single tab that helps them do it more efficiently and effectively.

Dr. Goehrs also shared with us about their pharmacovigilance technology named “Medication Shield” and the impact it’s having on drug prescribing in France.  The problem France faced was that there were hundreds of ways that side effects were recorded.  To address this challenge, Medication Shield goes through all these free text side effects and using AI were able to identify what side effects were being described by the patient so they could categorize them properly and identify potential harmful side effects.

Listen in to the video interview below to learn more from our neighbors across the pond on how they’re addressing medication reconciliation and pharmacovigilance in France and now in the US.

Learn more about Synapse Medicine: https://synapse-medicine.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top storiessubscribe to our newsletter.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.

Synapse Medicine is a proud sponsor of Healthcare Scene.

About the author

John Lynn

John Lynn is the Founder of HealthcareScene.com, a network of leading Healthcare IT resources. The flagship blog, Healthcare IT Today, contains over 13,000 articles with over half of the articles written by John. These EMR and Healthcare IT related articles have been viewed over 20 million times.

John manages Healthcare IT Central, the leading career Health IT job board. He also organizes the first of its kind conference and community focused on healthcare marketing, Healthcare and IT Marketing Conference, and a healthcare IT conference, EXPO.health, focused on practical healthcare IT innovation. John is an advisor to multiple healthcare IT companies. John is highly involved in social media, and in addition to his blogs can be found on Twitter: @techguy.

   

Categories